Summary
We have studied the effects of N-acetylcysteine which is thought to have antioxidant properties, on the susceptibility of low-density lipoprotein to oxidation and on whole-blood glutathione concentrations in six healthy volunteers.
N-acetylcysteine was given orally in a dosage of at 1.2 g per day for 4 weeks, followed by 2.4 g per day for a further two weeks. The susceptibility of low-density lipoprotein toin vitro Cu2+-oxidation was determined by continuously measuring the formation of conjugated dienes. Whole-blood concentrations of reduced and oxidized glutathione were also determined.
N-acetylcysteine had no effect on the susceptibility of LDL to oxidation. Concentrations of vitamin E in the serum and in low-density lipoprotein were not changed. Compared with controls the concentration of glutathione in N-acetylcysteine treated subjects was reduced (−48 %) and the concentration of oxidized glutathione was higher (+80%). The GSH/GSSG-ratio, a marker of oxidative stress was 83 % lower.
The results do not support the supposed antioxidative action of N-acetylcysteine. It seems more likely that N-acetylcysteine acts as a pro-oxidant in the dosage used.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Boman R, Backer U, Larsson S, Melander B and Wahlander L (1983) Oral acetylcysteine reduces exacerbation rate in chronic bronchitis. Eur J Resp Dis 64:405–415
Bridgeman MME, Marsden M, MacNee W, Flenley DC, Ryle AP (1991) Cysteine and glutathione concentrations in plasma and bronchoalveolar lavage fluid after treatment with N-acetylcysteine. Thorax 46:39–112
Carew TE, Schwenke DC, Steinberg D (1987) Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidantsin vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemie rabbit. Proc Natl Acad Sci USA 84:7725–7729
Ceconi C, Curello S, Cargoni A, Ferrari R, Albertini A, Visioli O (1988) The role of glutathione status in the protection against ischaemic and reperfusion damage: effects of n-acetylcysteine. J Mol Cell Cardiol 20:5–13
Corcoran GB, Wong BK (1986) Role of glutathione in prevention of acetaminophen-induced hepatotoxicity by N-acetyl-L-cysteinein vivo: studied with N-acetyl-D-cysteine. J Pharmacol Exp Ther 238:54–61
Curello S, Ceconi C, Cargnoni A, Cornacchiari A, Ferrari R. Albertini A (1987) Improved procedure for determining glutathione in plasma as an index of myocardial oxidative stress. Clin Chem 33:1448–1449
De Graaf J, Hak-Lemmers HLM, Hectors MPC, Demacker PNM, Hendriks JCM, Stalenhoef AFH (1991) Enhanced susceptibility toin vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arteriosclerosis and Thrombosis 11:298–306
Esterbauer H, Dieber-Rotheneder M, Waeg G, Striegl G, Eirgens G (1990) Biochemical, structural and functional properties of oxidized low-density lipoprotein. Chem Res Toxicol 3:77–92
Esterbauer H, Striegl G, Puhl H, Rotheneder M (1989) Continuous monitoring ofin vitro oxidation of human low density lipoprotein. Free Radical Res Commun 6:67–75
Gavish D, Breslow J (1991) Lipoprotein(a) reduction by N-acetylcysteine. Lancet 337: 203–204
Griffith OW (1985) Glutathione and glutathione disulfide. In: Bergmeyer HU (ed) Methods of enzymatic analysis. VCH, Weinheim
Henriksen T, Mahoney EM, Steinberg D (1981) Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. Proc Natl Acad Sci USA 78:6499–6503
Lauterburg BH, Corcoran GB, Mitchell JR (1983) Mechanism of action of N-acetylcysteine in the protection against the hepatotoxicity of acetaminophen in ratsin vivo. J Clin Invest 71:980–991
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
MÅrtensson J, Gustafsson J, Larsson A (1989) A therapeutic trial with N-acetylcysteine in subjects with hereditary glutathione synthetase deficiency (5-oxoprolinuria). J Inher Metab Dis 12:120–130
Multicenter Study Group (1980) Long-term acetylcysteine in chronic bronchitis. Eur J Resp Dis 61 [Suppl.]:93–108
Parthasarathy S (1987) Oxidation of low-density lipoprotein by thiol compounds leads to its recognition by the acetyl LDL-receptor. Biochim Biophys Acta 917:337–340
Parthasarathy S, Printz DJ, Boyd D, Joy L, Steinberg D (1986) Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor. Arteriosclerosis 6:505–510
Parthasarathy S, Young S, Witztum JL, Pittman RC, Steinberg D (1986) Probucol inhibits oxidative modification of low density lipoprotein. J Clin Invest 77:641–644
Perchellet EM, Maatta EA, Abney NL, Perchellet JP (1987) Effects of diverse intracellular thiol delivery agents on glutathione peroxidase activity, the ratio to reduced/oxidized glutathione, and ornithine decarboxylase induction in isolated mouse epidermal cells treated with 12-O-tetradecanoylphorbol-13-acetate. J Cell Physiol 131:64–73
Prescott LF, Illingworth RN, Critchley JAJH, Stewart MJ, Adam RD, Proudfoot AT (1979) Intravenous N-acetylcysteine: the treatment of coite for paracetamol poisoning. Br Med J 2:1097–1100
Saez G, Thornalley PJ, Hill HAO, Hems R, Bannister JV (1982) The production of free radicals during the auto-oxidation of cysteine and their effect on isolated rat hepatocytes. Biochim Biophys Acta 719:24–31
Sheffner AL (1963) The reductionin vitro in viscosity of mucoprotein solutions by a new mucolytic agent, N-acetyl-L-cysteine. Ann NY Acad Sci 106:298–310
Stalenhoef AFH, Kroon AA, Demacker PNM (1991) N-acetylcysteine and lipoprotein. Lancet 337:491
Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL (1989) Beyond cholesterol. Modification of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320:915–924
Steinbrecher U, Partahasarathy S, Leake DS, Witztum JL, Steinberg D (1984) Modification of low density lipoprotein by endothelial cells involves lipidperoxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA 81:3883–3887
Sunde RA, Hoekstra WG (1980) Structure, synthesis and function of glutathione peroxidase. Nutrition Reviews 38:265–273
Tietze F (1969) Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione. Anal Biochem 27:502–522
Viña J, Saez GT, Wiggins D, Roberts AFC, Hems R, Krebs HA (1983) The effect of cysteine oxidation on isolated hepatocytes. Biochem J 212:39–44
Ylä-Herttuala S, Palinsky W Rosenfeld, Parthasarathy S, Carew TE, Butler S, Steinberg D (1989) Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 84:1086–1095
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kleinveld, H.A., Demacker, P.N.M. & Stalenhoef, A.F.H. Failure of N-acetylcysteine to reduce low-density lipoprotein oxidizability in healthy subjects. Eur J Clin Pharmacol 43, 639–642 (1992). https://doi.org/10.1007/BF02284964
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02284964